Search
Now showing items 1-5 of 5
SARS-COV-2 REINFECTION
(2022 , Master Thesis)
Background: SARS-CoV-2 reinfection investigation is on rise, and despite the fact that reviews and studies have attempted to study and define reinfection, none have compared it with all documented conditions in the literature. ...
ANTIBODY DEPENDENT ENHANCEMENT (ADE) - CAUSE OF DISEASE SEVERITY IN CORONAVIRUS INFECTED AND/OR VACCINATED INDIVIDUALS
(2024 , Master Thesis)
Aim: This study evaluated the potential for ADE in serum samples from patients exposed to SARS-CoV-2 (Severe acute respiratory syndrome-coronavirus-2) and MERS-CoV (Middle East Respiratory Syndrome-coronavirus). For ...
CHARACTERIZING WITHIN-HOST DIVERSITY IN SHORT-TERM AND VACCINATED COVID-19 PATIENTS
(2023 , Master Thesis)
SARS-CoV-2 is the etiological agent of the ongoing COVID-19 pandemic, which has caused massive losses in human lives and strained global health resources. The ongoing vaccination campaigns in many countries have spurred ...
UNRAVELING THE MICROBIOME DIVERSITY AND DYNAMICS IN DIFFERENT SAMPLE TYPES DURING CORONAVIRUS INFECTIONS
(2024 , Master Thesis)
Background: Mucosal immunity and gut microbiome influence respiratory diseases like those caused by coronaviruses (HCoV). This study explores the relationship between HCoV infection and the respiratory and gut microbiome. ...
NASAL EXPRESSION OF ANIOTENSIN-CONVERTING ENZYME 2 (ACE2) IN CHILDREN AND ADULTS WITH COVID-19
(2021 , Master Thesis)
"Emerging evidence suggests that the lower expression of SARS-CoV-2 entry factor angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in the nasal epithelium of children may contribute to ...